The rate of Bitcoin BTCUSD has risen by 1.55% since yesterday.TradingView”>
On the hourly chart, the price of BTC has made a false breakout of the local resistance of $115,258. As most of the daily ATR has been passed, there are low chances of seeing sharp moves by tomorrow.
However, if the candle closes near the resistance, growth may continue to $116,000 within the next days.TradingView”>
On the longer time frame, the rate of the main coin is rising after yesterday’s bullish closure. If the bar closes near $116,000 with no long wick, the accumulated energy might be enough for a move to the $117,000-$119,000 zone.TradingView”>
From the midterm point of view, it is too early to make any long-term predictions. The volume has declined, which means sideways trading in the area of $114,000-$120,000 is the most likely scenario.
DeFi continues to evolve as a core component of the crypto ecosystem, with the total value locked (TVL) rebounding from a low of $36.59 billion in October 2023 to over $90 billion as of early 2024 [1]. This recovery highlights a shift in investor sentiment and underscores the growing importance of DeFi in 2024. The sector is now marked by a set of emerging trends that could reshape decentralized finance and its integration with traditional financial systems.
One of the most notable trends is the rise of , which offer real yield and greater flexibility for liquidity providers [1]. Platforms such as GMX and Jupiter have gained traction for their perpetual trading-based LP models, allowing users to earn yields ranging from 30% to 120% APY. These pools reduce the need for constant monitoring and provide stable, long-term returns, making them an attractive alternative for those seeking exposure to the broader crypto market without the volatility associated with direct asset ownership.
The concept of is also gaining momentum. This approach allows users to define their desired outcomes rather than specifying the exact parameters of each transaction, streamlining the DeFi experience [1]. Protocols like UniswapX and Aperture Finance are leading the charge by leveraging AI and smart contracts to optimize trade execution and simplify complex DeFi interactions. These advancements are crucial for onboarding new users and reducing the technical barriers that have historically limited mass adoption.
Airdrops and points-based systems continue to play a pivotal role in . Projects like EigenLayer, Ethena, and Solana’s Saga smartphone have effectively used airdrops and points to reward active users and foster loyalty [1]. These strategies not only incentivize participation but also contribute to the long-term sustainability of DeFi protocols by creating a decentralized, active user base.
remain a cornerstone of DeFi innovation, allowing users to stake their assets while maintaining liquidity [1]. Lido Finance is a prime example, offering liquid staking tokens (LSTs) that can be used across multiple DeFi applications. Emerging developments, including restaking and integration with Layer 2 solutions, are expanding the utility of these protocols and enhancing yield opportunities for participants.
Cross-chain interoperability is another key trend, with like Axelar, Hyperlane, and Chainlink’s CCIP enabling seamless asset transfers across different blockchain networks [1]. These protocols are not only improving liquidity and access to DeFi services but also addressing security concerns through innovations such as decentralized liquidity pools and AI-driven risk management. Despite past vulnerabilities in bridge security, the industry is making strides toward more robust and scalable solutions.
The tokenization of is also gaining traction as a means to attract institutional capital into the crypto space [1]. Platforms such as Ondo Finance and Realio are leveraging blockchain to tokenize treasuries and other physical assets, offering stable yields and regulatory compliance. This trend is particularly significant in the wake of major crypto collapses, as investors seek safer, more diversified options within the digital asset landscape.
On the Bitcoin network, are unlocking new DeFi capabilities, enabling the creation of smart contracts and decentralized applications. The Lightning Network, Stacks, and RSK are at the forefront of this movement, expanding Bitcoin’s functionality beyond peer-to-peer transactions. These developments are attracting developers and users alike, with over 200 Ethereum-based dApps already adapted for Bitcoin, signaling a broader convergence between the two ecosystems.
Finally, are seeing a resurgence, driven by major global events such as the 2024 U.S. Presidential election and the UEFA Euro Cup [1]. Platforms like Polymarket are experiencing record trading volumes and user growth, with TVL in the sector rising by 57.7% year-to-date. These markets provide a unique mechanism for aggregating collective expectations and have the potential to play a critical role in the future of DeFi.
As DeFi continues to evolve, it faces challenges such as liquidity fragmentation and user experience limitations [1]. However, the pace of innovation remains high, with new financial primitives and market structures emerging to address these issues. The coming months will likely see further consolidation around dominant protocols and market approaches, shaping the next phase of DeFi’s development.
Source: [1]DeFi Trends to Watch in 2024 (https://www.coingecko.com/learn/defi-trends-crypto)
Silver (XAG/USD) gains 0.39% to $37.88 amid broad US Dollar weakness; DXY drops over 0.50%.
Market sentiment lifted by corporate earnings and Apple–Trump joint $100B investment announcement.
Trump threatens 100% tariffs on foreign-made chips, exempts US-based production.
Silver Price advances during the North American session, up by 0.39% as the Greenback weakens more than 0.50%, as revealed by the US Dollar Index (DXY). At the time of writing, the XAG/USD trades at $37.88 after hitting a low of $37.31.
Sentiment improved due to earnings and Trump’s threat to impose 100% duties on chips. However, an exemption was made for companies producing items in the US, as Apple CEO and Trump announced a fresh $100 billion investment in the country.
XAG/USD Price Forecast: Technical outlook
From a technical perspective, the Silver price is neutral-biased, from a price action point of view, capped on the upside by the 20-day SMA at $38.04. However, sentiment turned slightly bullish, as seen by the Relative Strength Index (RSI), which cracked the index neutral line three days ago.
If XAG/USD ends daily above the 20-day SMA, look for a rally toward $39.00. Further resistance lies above, with the July 25 high of $39.19, followed by the YTD peak at $39.52.
Conversely, if XAG/USD finishes the session below $38.00, this could prompt sellers to drive the grey metal below he August 5 daily low of $37.31, sponsoring a slide towards $37.00. On further strength, the grey metal could reach the 50-day SMA at $36.73.
XAG/USD Price Chart – Daily
Silver FAQs
Silver is a precious metal highly traded among investors. It has been historically used as a store of value and a medium of exchange. Although less popular than Gold, traders may turn to Silver to diversify their investment portfolio, for its intrinsic value or as a potential hedge during high-inflation periods. Investors can buy physical Silver, in coins or in bars, or trade it through vehicles such as Exchange Traded Funds, which track its price on international markets.
Silver prices can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can make Silver price escalate due to its safe-haven status, although to a lesser extent than Gold’s. As a yieldless asset, Silver tends to rise with lower interest rates. Its moves also depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAG/USD). A strong Dollar tends to keep the price of Silver at bay, whereas a weaker Dollar is likely to propel prices up. Other factors such as investment demand, mining supply – Silver is much more abundant than Gold – and recycling rates can also affect prices.
Silver is widely used in industry, particularly in sectors such as electronics or solar energy, as it has one of the highest electric conductivity of all metals – more than Copper and Gold. A surge in demand can increase prices, while a decline tends to lower them. Dynamics in the US, Chinese and Indian economies can also contribute to price swings: for the US and particularly China, their big industrial sectors use Silver in various processes; in India, consumers’ demand for the precious metal for jewellery also plays a key role in setting prices.
Silver prices tend to follow Gold’s moves. When Gold prices rise, Silver typically follows suit, as their status as safe-haven assets is similar. The Gold/Silver ratio, which shows the number of ounces of Silver needed to equal the value of one ounce of Gold, may help to determine the relative valuation between both metals. Some investors may consider a high ratio as an indicator that Silver is undervalued, or Gold is overvalued. On the contrary, a low ratio might suggest that Gold is undervalued relative to Silver.
The European dietary supplements market, worth more than 87 billion euros in 2024, is booming.
Food giants like Nestlé and Unilever push supplements with claims of better health, but nearly half of these claims violate EU advertising regulations, an investigation focusing on the Netherlands has found.
Why does it matter?
Consumers across Europe buy into promises that supplements can boost immunity, ease symptoms of the menopause, or improve stress and sleep.
But many of these claims lack scientific backing or are outright illegal under EU rules, while some supplements may pose health risks or delay necessary medical treatment
How did we investigate this?
For Follow the Money, The Investigative Desk submitted 437 supplements marketed in Europe to a self-regulatory review body.
We analysed claims against EU rules and found widespread violations, illustrating how enforcement gaps and influencer marketing fuel misleading narratives across the bloc.
The verdict? “Ten out of ten,” says German-Malaysian influencer Caroline Nest to her 533,300 TikTok followers, as she sweeps a blow-dried strand of hair out of her face with a manicured hand.
“Normally, I’m not a big fan of vitamin gummies, but this brand from Kourtney Kardashian, Lemme – what is this?” she says, with a mixture of disbelief and admiration.
She holds up three pastel-coloured jars to the camera: Lemme Chill for relaxation, Lemme Purr for vaginal freshness, and Lemme Curb to suppress sweet cravings.
In another video, Nest is especially enthusiastic about Lemme Sleep, which contains melatonin, L-theanine and “dreamy botanicals,” according to the product’s website. “When I say I’m gone in five minutes after taking these, I’m not lying,” she enthuses.
Dubious promises lie at the heart of a multi-billion-euro market that has grown exponentially in recent years
The opinions of food nutrition experts, however, are starkly different.
“This is pure consumer deception,” said Renger Witkamp, a professor of nutrition and health at Wageningen University in the Netherlands.
The fact that Lemme is backed by food giant Unilever – known for producing ultraprocessed foods such as mayonnaise, sausages, and ice cream – makes the marketing of such supplements even more cynical, according to Witkamp.
“If you eat and live healthily, there’s no reason to take all these extras,” he said.
Only in specific cases, such as when people are vegan, pregnant, or on certain medications, might such supplements be useful, the professor emphasised.
But manufacturers such as Unilever and Nestlé are keen to promote the increasingly lucrative idea that health can come from a jar of supplements – even if this promotion contravenes EU regulations.
The Investigative Desk, a group of specialised journalists, collected the health claims made by these supplements and found that nearly half of them broke such rules.
Yet the products are widely sold online and in stores, allowing food giants to earn tens of billions from supplements that are, in the view of many experts, at best unnecessary and at worst actively harmful.
Nestlé and Unilever
The investigation focused on supplements available in the Netherlands, and backed by the 10 largest food companies on the European market.
The claims made for 437 products were submitted in mid-May to the Keurinsgraad, a self-regulatory body established by the Dutch supplement industry, to see whether they were consistent with EU regulations.
The body found that the advertising for 212 of these supplements contravened EU regulations – almost half of the total.
Among Unilever-backed supplements available in the Netherlands, 68 of 72 products carried unauthorised claims on their packaging or in advertising.
Our journalism is only possible thanks to the trust of our paying members. Not a member yet? Sign up now
Of the 354 Nestlé products, 115 made claims that had not been authorised, such as “supports healthy blood” or “helps maintain a responsible cholesterol level”.
Twenty-three Nestlé products carried “on hold” claims, which have not yet been evaluated by the European Commission.
And 18 Nestlé products even carried medical claims – statements reserved for medicines – like “has anti-inflammatory properties”.
The investigation found a total of 24 dietary supplements sold in the Netherlands – statements suggesting that a product can prevent, treat or cure disease, which is not allowed for food supplements under EU law.
A more limited investigation into the French and German markets found 17 and 16 products that made unauthorised medical claims, respectively. Some of the differences stem from how the claims were translated.
In response to this investigation, Nestlé and Unilever both said that their products and related claims complied with local legislation.
Surging revenues
These dubious promises lie at the heart of a multi-billion-euro market that has grown exponentially in recent years.
In 2024, the European nutritional supplements market was valued at more than 87 billion euros, with forecasts projecting it will exceed 124 billion euros by 2030, according to U.S.-based market research firm Grand View Research.
Vitamins remain the leading product category. While capsules and tablets continue to dominate, alternative formats such as gummies are rapidly gaining ground.
By 2040, 58 per cent of expected consumption of vitamins, minerals, and supplements will be from millennials and Gen Z
Once mainly used by athletes, pregnant women, and the elderly, supplements have become popular lifestyle products, fuelled by online influencers and accelerated by consumers seeking to boost immunity and health during the COVID-19 pandemic.
Jostein Solheim, CEO of Health and Wellbeing at Unilever, told shareholders in 2022 that the market had shifted from “health as the absence of disease” to “health as a lifestyle”.
He noted that younger generations were especially receptive: “By 2040, 58 per cent of expected consumption of vitamins, minerals, and supplements will come from millennials and Gen Z.”
Nestlé has also invested heavily in supplements. Through Nestlé Health Science, the company began developing supplements in 2014 and acquired the developer and producer Atrium Innovations for 2.3 billion dollars in 2017.
Beyond the legitimacy of the claims, taking supplements can carry risk. Excessive vitamin B6 consumption, for example, can cause permanent nerve damage.
Herbal supplements can also interact dangerously with medications. Tryptophan – sold by Nestlé brands AOV and Orthica – has been found to intensify the effects of sleep aids, and cause restlessness or nausea when combined with antidepressants.
Professor Witkamp of Wageningen University also warned that the herb St. John’s Wort can interact with certain medications, including birth control, antidepressants, and blood thinners. But such risks are not required on labels under EU regulations.
“That’s where it goes wrong,” he says. “The information is known to regulators, but it doesn’t reach consumers.”
Another risk is that people decide to take supplements rather than consult a medical professional.
For example, a French Solgar product called Baie de Saw Palmetto claims: “Widely used in herbal medicine, turmeric helps maintain joint flexibility and comfort.”
This botanical claim is currently on hold, awaiting approval by the European Union.
In the Netherlands, such claims must be accompanied by an asterisk (*) to indicate that the claim has not yet been officially approved. However, in countries like France and Germany, this is not mandatory.
As a result, it becomes even more difficult for consumers to understand that these health claims have not been verified or authorised.
“Consumers don’t really understand what that means,” said Professor Witkamp. A patient with joint problems relying on such products may therefore delay seeking proper medical care.
Loopholes and work-arounds
Even the 212 products that were found to comply with EU advertising regulations as part of this investigation used claims that were dubious in other ways.
For example, there are no approved health claims for ingesting collagen. “The body breaks it down, so it doesn’t reach where it’s needed,” said Witkamp.
But vitamin C does have an approved claim, and so companies use the vitamin to their collagen products, allowing them to legally say it’s “good for cartilage” – even though this comes from the vitamin C, not the collagen.
“Drink water, eat a banana, have some broth. It’s cheaper too”
Even supplements with approved health claims may be far less effective than they appear.
Turmeric, for example, is found in countless supplements claiming to support not only joints, but also digestion and memory.
But recent research by Maurice Kroon at the University of Amsterdam shows that its active compound, curcumin, is barely absorbed by the body.
Cosmetic claims are another loophole. While saying a supplement benefits “skin, hair, and nails” is not allowed, it is permitted to say that it helps the “appearance of skin, hair, and nails”.
Medical professionals say expensive supplements are often not even necessary.
Unilever’s “Liquid I.V. hydration powder” claims to help the body absorb water better by harnessing the power of electrolytes and carbohydrates.
Professor Liffert Vogt, a kidney specialist, advised healthy consumers to “just drink water. Your body absorbs it very well on its own.”
Such drinks are only helpful during illness, he said. “Drink water, eat a banana, have some broth. It’s cheaper too.”
‘Why even have EU laws?’
These EU rules apply everywhere the product is advertised: whether that be on the label, on television, websites or social media.
Social media and web regulation is crucial, as ever more people are finding out about and buying supplements online.
In 2019, around 19 per cent of people who took supplements bought these products through the internet – today, that figure has doubled.
This makes enforcement harder, as many of these products are manufactured in the United States, where laws are more relaxed.
U.S. brands use influencers like Caroline Nest in Germany, Michelle Bruin in Holland and Jessica Roux in France, to promote their products, linking to foreign sites that show unauthorised claims.
The American brand Puritan’s Pride is therefore able to tell European consumers that its products can “cross the blood brain barrier” and “reduce risk of eye conditions” – statements that contravene EU rules.
Professor Hans Verhagen, a certified nutritionist who was part of a team that assessed thousands of claims for the European Food Safety Authority from 2005 to 2016, is dismayed that such misleading information is still being spread in the continent.
Fines for violators range from 525 euros for small firms to 1,050 euros for larger ones. For companies like Nestlé and Unilever, with turnover in the billions, that is not much of a deterrent.
Verhagen argued that food watchdogs need to step up enforcement.
“Companies must follow the law,” Verhagen said.
“If they don’t, why even have EU laws?”
Responses
Anya Pieroen, Head of Corporate Communications and Affairs at Nestlé Netherlands BV, said:
“All packaging and related claims we develop comply with applicable European and local legislation. Claims are carefully reviewed in advance before products are placed on the market.
Any communication that comes directly from Nestlé or its brands, such as on the websites of AOV and Orthica, is based on current laws and regulations. For external sales channels, we provide accurate and substantiated product information and explicitly advise that this information be used in accordance with applicable legislation.
Since we do not have control over all third-party communications – such as online stores or influencers – we cannot fully monitor those. In response to this research, we will hold internal discussions on how to better inform third parties about the applicable regulations and the correct use of claims.”
Willemijn Storimans, Strategy and External Affairs Manager in Europe for Unilever’s food portfolio, said:
“Consumer safety is of the utmost importance to Unilever. All our products, and the ingredients they contain, undergo rigorous safety evaluations.
We take compliance seriously and adhere to local laws and the relevant approval processes, where applicable. All claims on our products are subject to a thorough verification and approval process.”
The Investigative Desk is a group of specialized investigative journalists. They finance their work through donations, grants, subsidies, and fees. Funders have no role in or influence over the investigations or the content of the publications. More information can be found at www.investigativedesk.com.
Cardano has failed to live up to the hype in 2025, with ADA price action falling short of investor expectations. While some analysts still hold out hope for a modest 3x return this cycle, the spotlight is shifting elsewhere.
Remittix (RTX) is gaining serious traction for its real-world payments utility, and analysts say it could deliver 45x gains as adoption surges in Q4 and beyond.
ADA Price Shows Strength on Daily Charts but Weakness on Lower Timeframes
Cardano has had its fair share of hype, but 2025 hasn’t delivered what long-term holders hoped for. Despite holding above $0.75, the ADA Price is showing signs of fatigue. The chart might still look bullish on the daily, but momentum is slowing. And with Cardano News now quieter than ever, the sentiment around this token feels muted.
On the 4-hour timeframe, the structure looks weak. Traders are watching a potential break below key support, with volume thinning out. The ADA Prediction for this cycle has been revised by several analysts, with many now suggesting that a 3x return might be the most realistic outcome. That’s far from the explosive moves many expected after Alonzo and Hydra upgrades.
Even the much-discussed $0.81 liquidity target looks shaky. Price is hovering too long without making a strong move, and that indecision doesn’t favor bulls. At best, Cardano Price Prediction targets are getting more conservative by the week.
And while ADA Price today might seem stable, it feels like a stall before a bigger directional move, and not necessarily upward. Confidence has dipped, and attention is shifting elsewhere.
Remittix Emerges as a Top Contender With Real Utility and 45x ROI Potential
While Cardano Price prediction continues to underwhelm in 2025, Remittix (RTX) is cutting through the noise with one thing traditional Layer-1s often lack real financial impact. This isn’t another “future-ready” blockchain. It’s a live payment rail built for users who need crypto to work. Fast. Cheap. Globally.
The project is gaining massive traction because it solves a real problem: expensive and slow international transfers. Unlike ADA, which still struggles to find large-scale use beyond staking and speculation, Remittix is already powering frictionless cross-border payments.
Backed by over $18.1 million raised and more than 581 million tokens sold, now selling at $0.0895, investor belief is strong. It’s now on track to hit 45x returns by tackling real-world use cases with one clear mission: move money without the nonsense.
Key reasons Remittix is outperforming ADA in 2025:
Supports 50+ crypto pairs and 30 fiat currencies through one seamless platform
Enables crypto-to-fiat transfers with direct bank account payouts in under 24 hours
Staking, rewards, and full PayFi features are all built around the $RTX token
$250,000 Remittix Giveaway, creating additional demand and onboarding
With the Remittix Wallet beta set for September 15, the team is moving fast toward full utility. And if early indicators hold, this might be the DeFi project everyone remembers for being “the one that actually delivered.”
Discover the future of PayFi with Remittix by checking out their project here:
Press releases or guest posts published by Crypto Economy have been submitted by companies or their representatives. Crypto Economy is not part of any of these agencies, projects or platforms. At Crypto Economy we do not give investment advice, if you are going to invest in any of the promoted projects you should do your own research.
– Beam Ventures launches $150M fund in Abu Dhabi to boost Web3 gaming, AI, and blockchain startups under ADGM jurisdiction.
– Government-backed initiative targets early-stage innovation, leveraging AI/blockchain to reshape gaming and attract global investment.
– Abu Dhabi aims to replicate Singapore/South Korea’s success by fostering tech ecosystems through strategic infrastructure and regulatory support.
– Fund aligns with global Web3/AI investment trends, positioning the city as a hub for next-generation digital innovation and economic diversification.
Biote narrowly missed revenue forecasts last quarter, but booming supplement sales pushed both profit and future projections well above Wall Street’s hopes.
What does this mean?
Biote—the hormone therapy and wellness provider—reported second-quarter revenue of $48.90 million, just under LSEG’s $49.50 million estimate. While demand for Biote’s core medical procedures slowed and is expected to keep dipping into next year, sales of dietary supplements spiked 30% compared to last year. That growth helped net income climb to $3.9 million and lifted gross margins to 71.6% as Biote streamlined costs and boosted supply chain efficiency. Adjusted EBITDA for the quarter came in at $15.2 million, with operating income at $10.8 million and per-share earnings of $0.10. Management now sees 2025 revenue topping $190 million and adjusted EBITDA over $50 million, with supplement sales picking up the slack from declining procedures. Wall Street analysts are buying in: all six tracked recommend Biote, setting a $7.00 median price target—over 40% above the current share price.
Why should I care?
For markets:Wellness sector’s staying power shines through.
Biote’s double-digit supplement growth is propping up confidence despite slowing core procedures—a shift that’s showing up in improved margins and strong analyst support. With shares trading at a modest eight times forward earnings and every analyst on board, investor sentiment looks resilient. The company’s pivot from one-off procedures to higher-margin, recurring wellness products is grabbing attention as more see supplements as a steady, long-term play.
The bigger picture:Supplements rewrite the wellness industry playbook.
Biote’s strategy reflects a broader push across the wellness space to favor scalable, recurring revenue streams over traditional clinical services. Rising supplement sales hit on consumer preferences for ongoing self-care, while management’s push for efficiency and supply chain control could set a stronger foundation for future growth. As more companies trade treatments for wellness products, the industry may be setting up for a more defensible and diversified future.
The cryptocurrency market is closely watching the progress of Ripple’s efforts to secure approval for the first-ever XRP ETF, a move that could mark a turning point in the broader altcoin landscape. Following years of legal uncertainty, Ripple is reportedly in advanced discussions with major financial institutions, including BlackRock and Fidelity, which could soon file the necessary ETF paperwork once the ongoing settlement with the SEC is finalized. This development may significantly enhance institutional access to XRP and inject billions into the asset class, potentially driving a renewed altcoin rally [1].
Historical patterns suggest that ETF approvals for major cryptocurrencies often trigger sharp price surges. For example, Bitcoin and Ethereum experienced significant gains around the time of their respective ETF approvals. XRP, currently trading near $2.45, could see a similar trajectory, with some forecasts suggesting a potential return to its historical high of $3.84 or even higher [2]. The broader crypto market is already showing signs of increased activity, with investors redirecting capital toward altcoins that could benefit from XRP’s momentum [3].
Among the altcoins gaining attention is MAGACOIN FINANCE, a project that has attracted speculative interest due to its low market cap and potential for substantial returns. Analysts highlight its growing community and real-world utility, suggesting it could outperform during an XRP-driven rally [4]. The project’s presale has already generated significant traction, and some market observers are drawing comparisons between its potential and XRP’s performance during its 2017 bull market [5].
August 2025 is emerging as a pivotal timeframe for XRP and the altcoin sector. The joint status update between Ripple and the SEC, due on August 15, is widely expected to clarify the final terms of their settlement, which could clear the way for the ETF’s approval. In the interim, speculative interest is building, particularly in projects with high upside potential and strong community engagement [6].
The potential approval of an XRP ETF could also validate the broader altcoin market as a legitimate investment class. Institutional participation in XRP has already increased, with firms like SBI expressing confidence in the ETF’s role in enhancing liquidity and price stability [7]. If the ETF is approved, it could serve as a catalyst for renewed market optimism, potentially triggering a broader rally across the altcoin sector.
Market participants are also tracking large movements in XRP, including a recent $58 million whale transfer, which has fueled speculation about further upward movement. These developments suggest that the market is increasingly positioning for a potential breakout above $3.00, with further gains possible as regulatory clarity emerges [8].
As the industry awaits official news, the narrative surrounding XRP ETF approval continues to evolve. If it materializes, it could not only reinforce XRP’s standing in the crypto market but also signal the start of a new altcoin cycle. For investors seeking opportunities beyond the top 10 cryptocurrencies, MAGACOIN FINANCE has emerged as a notable contender, with some analysts forecasting breakout-level gains should XRP’s rally materialize.
Three crypto assets—DeSoc, Avalanche (AVAX), and Cardano (ADA)—are increasingly being positioned as top buys for 2025, driven by DeFi integration, social utility, and long-term growth potential. DeSoc, a decentralized social Layer 1 platform, is attracting attention for its Social-DeFi model, which rewards user engagement with $SOCS tokens. By enabling on-chain content sharing and tipping through gasless transactions, the platform is redefining how social interactions generate value. Unlike traditional utility tokens, SOCS incentivizes creators and users to participate in a transparent, community-driven ecosystem [1]. Ripple and AVAX holders are reportedly shifting their focus to DeSoc, betting on its ability to outperform utility-based tokens [2]. The project’s presale has seen rapid uptake, fueled by its unique monetization of user activity and cross-platform compatibility [7].
Avalanche (AVAX) continues to gain traction following the activation of the “Blizzard” upgrade, which improved consensus efficiency and reduced block times. The token has surged by 28% over the past month, outperforming broader crypto markets [3]. AVAX recently broke past key support at $21.40, with analysts forecasting a potential trading range of $37.70–$41.10 by year-end. The Avalanche Foundation has also launched a $200 million fund to support ecosystem growth, and open interest for AVAX futures has reached a record high of $796.35 million [4]. These developments underscore strong investor confidence in the platform. The expansion of AVAX’s developer ecosystem and the rise in total value locked (TVL) above $1 billion further highlight its growth trajectory [5]. DeSoc is now offering AVAX holders a new avenue to apply on-chain earnings toward social incentives, reinforcing Avalanche’s position as a top Ethereum alternative.
Cardano (ADA) is being highlighted for its 2025 growth potential, with its Alonzo upgrade and Hydra scaling plans driving increased utility. ADA has risen 4% this week following new on-chain identity partnerships in Africa. The token is consolidating above $0.76, with traders watching for a potential move toward $0.82. Analysts project ADA could reach $1.80 by late 2025, supported by rising smart contract adoption and the upcoming Hydra rollout [1]. Cardano’s academic approach and focus on formal verification continue to attract high-quality developers, positioning it as a foundational player in the DeFi and NFT ecosystems. While less hyped than DeSoc, ADA is expected to benefit from increasing institutional interest in the second half of 2025 [6].
Collectively, DeSoc, AVAX, and Cardano are shaping a compelling narrative for crypto investors. DeSoc, in particular, is emerging as a top buy now, with some forecasts suggesting it could outperform Cardano, XLM, and Ethereum [8]. The testnet launch of DeSoc is expected to provide critical insights into its scalability and functionality. Investors are advised to monitor how the platform balances tokenomics with user incentives, a factor that will determine its long-term viability. Meanwhile, AVAX’s infrastructure upgrades and Cardano’s institutional appeal are reinforcing their positions as key altcoin plays in a market increasingly open to innovation [3].
Corporate treasury firms are increasingly allocating capital to Solana (SOL), signaling renewed confidence in the blockchain platform despite recent market turbulence. Firms such as Upexi and DeFi Development are among the leading investors, with Upexi holding 1.9 million SOL and DeFi Development holding 1.1 million SOL. While Upexi has incurred a $0.9 million loss due to price declines, DeFi Development has maintained a relatively stable performance. This growing institutional exposure suggests a broader acknowledgment of Solana’s utility in treasury strategies, particularly among early adopters [1].
The increasing rate of corporate Solana acquisition is supported by data from CoinGecko, which shows a sharp uptrend in institutional holdings. Upexi’s aggressive strategy has made it the top holder, but this approach has also exposed the firm to significant short-term volatility. Meanwhile, DeFi Development’s more measured approach has allowed it to retain value amid market fluctuations. The trend reflects a broader shift in the corporate treasury market toward digital assets, with Solana emerging as a key contender in the space [2].
Despite the growing interest, Solana’s price volatility remains a challenge. As of late July 2025, SOL was trading at around $170.69, with a 4.83% increase observed in the past 24 hours. However, the broader trend remains uncertain, with some analysts forecasting a potential 10% price correction before any meaningful recovery could take hold. This uncertainty has created a cautious environment for investors, even as buying pressure intensifies at lower price levels [3].
Retail and institutional traders alike have been closely watching whale activity, which has played a pivotal role in shaping short-term market dynamics. Observations suggest that large investors are accumulating Solana at discounted levels, which has fueled speculation that the price could test the $200 level again in the near future. While bullish forecasts have emerged, with some analysts projecting a price target of $500, more conservative views remain focused on short-term price stability [4].
The growing interest in Solana treasuries is not limited to native tokens. The broader Solana ecosystem has seen a resurgence, particularly with the performance of tokens like Pump.fun’s PUMP, which has drawn attention to the platform’s innovation potential. This diversification of investment opportunities has reinforced the belief that Solana is more than just a fast, low-cost blockchain—it is a growing infrastructure for decentralized finance and digital innovation [5].
The current state of Solana treasuries indicates that early investors and institutional players are positioned to benefit if the market stabilizes. However, the path to recovery is likely to be uneven, with further volatility expected in the short term. As corporate treasuries continue to allocate capital to Solana, the actions of these major holders will play a critical role in determining the asset’s trajectory in the months ahead.
BTCUSD has risen by 1.55% since yesterday.TradingView”>
